Webdesk: To prevent infectious diseases, the WHO and partners created a global pathogen genomics network.
The new International Pathogen Surveillance Network (IPSN) connects nations and regions to better sample collection, analysis, data-driven public health decision-making, and information exchange.
Pathogen genomics investigates the genetic code of viruses, bacteria, and other diseases to determine infectiousness, lethality, and transmission patterns. This vital information helps scientists and public health officials detect and track diseases, prevent outbreaks, and create effective treatments and medicines.
Moreover, The IPSN unites genomics and data analytics experts from governments, charity foundations, multilateral organisations, civil society, academia, and the corporate sector to the WHO Hub for Pandemic and Epidemic Intelligence. All parties aim to prevent pandemics and improve disease surveillance.
“The goal of this new network is to give every country access to pathogen genomic sequencing and analytics as part of its public health system,” said WHO Director-General Tedros Adhanom Ghebreyesus. “United against health risks, the world was stronger during COVID-19.”
While, COVID-19 pandemics depend on pathogen genetics. SARS-CoV-2 genome sequencing accelerated vaccine development. Genomic study has found more transmissible viral strains. Genomic analysis aids foodborne illness, influenza, TB, and HIV surveillance and pandemic preparedness. Monitoring HIV drug resistance has enabled life-saving antiretroviral therapy.
Moreover, The Rockefeller Foundation President Dr. Rajiv J. Shah emphasised worldwide pathogen genomic surveillance during COVID-19. He applauded the IPSN’s mission of fostering knowledge exchange, tools, and best practises across sectors and borders to enable innovative and strong pandemic prevention and response.
Many nations lack sample collection, analysis, and data utilisation in public health decision-making despite genetic advances from the epidemic. Global health surveillance requires more than sharing data, practises, and technologies. Even high-income nations are slashing pandemic-inflated spending to create capacity rapidly.
